Policy News
-
Life Sciences Day on the Hill
Utah’s vibrant life sciences industry was on full display yesterday as part of the Governor’s Office of Economic…
-
Trump Touts Healthcare Polices, Drug Pricing in State of the Union
In his State of the Union address February 5, President Trump highlighted a number of health policy goals,…
-
Trump May Look to Advance International Pricing Index
Game On: Groups Launch Competing Drug Pricing Ad Campaigns With prospects dim, at least in the short-term, for…
-
Senate Passes USMCA – Heads to the President’s Desk
The Senate on Thursday passed President Trump’s United States-Mexico-Canada Agreement (USMCA) by a wide bipartisan vote of 89-10.…
-
Positioning on Drug Pricing Continues
Sen. Grassley Calls on Pelosi to Support His Bill Conservative Group Backs GOP Drug Pricing Alternative As we…
-
Congress Reconvenes: Drug Pricing, USMCA updates
Congress returned yesterday with a number of big ticket items on their plate, including drug pricing and the…
-
HHS/FDA ADVANCE DRUG IMPORTATION WITH PROPOSED RULE
On December 18, HHS and the FDA issued a Noticed of Proposed Rulemaking (NPRM) that would allow states…
-
House Passes Pelosi Drug Pricing Plan
On Thursday, the Democrat-led House passed H.R. 3, the Lower Drug Costs Now Act, by a vote of…
-
MDMA, AdvaMed, MITA and a Broad Coalition of Stakeholders Urge Congress to Permanently Repeal the Medical Device Tax
Washington, DC – The Medical Device Manufacturers Association (MDMA), the Advanced Medical Technology Association (AdvaMed), the Medical Imaging &…
-
Grassroots Alert: Sign the Letter to Congress to End the Medical Device Tax
The Medical Device Manufacturers Association (MDMA), along with AdvaMed and the Medical Imaging Technology Association, is circulating a…
-
Device Companies Would Have to Report Product Samples Under STAR Act
Drug pricing legislation moving through Congress could force medical device manufacturers to report the value of product samples…
-
BioUtah Has a New Home!
We’re excited to announce that as of May 1, BioUtah has opened new offices downtown at 230 East…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
